Detalhe da pesquisa
1.
Layering vaccination with antibiotic therapy results in protection and clearance of Burkholderia pseudomallei in Balb/c mice.
Infect Immun
; 92(3): e0045523, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289122
2.
Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection.
Antimicrob Agents Chemother
; 65(6)2021 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33753342
3.
Demonstration of the broad spectrum in vitro activity of finafloxacin against pathogens of biodefence interest.
Antimicrob Agents Chemother
; 63(12)2019 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31570393
4.
Demonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.
Antimicrob Agents Chemother
; 61(7)2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28438936
5.
Liposome encapsulation of ciprofloxacin improves protection against highly virulent Francisella tularensis strain Schu S4.
Antimicrob Agents Chemother
; 58(6): 3053-9, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24637682
6.
In Vitro Activity of Finafloxacin against Panels of Respiratory Pathogens.
Antibiotics (Basel)
; 12(7)2023 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37508192
7.
In Vitro Activity of Novel Topoisomerase Inhibitors against Francisella tularensis and Burkholderia pseudomallei.
Antibiotics (Basel)
; 12(6)2023 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37370302
8.
The BALB/c Mouse Model for the Evaluation of Therapies to Treat Infections with Aerosolized Burkholderia pseudomallei.
Antibiotics (Basel)
; 12(3)2023 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36978372
9.
Efficacy of finafloxacin in a murine model of inhalational glanders.
Front Microbiol
; 13: 1057202, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36504783
10.
Investigation of a combination therapy approach for the treatment of melioidosis.
Front Microbiol
; 13: 934312, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051754
11.
An Investigation into the Re-Emergence of Disease Following Cessation of Antibiotic Treatment in Balb/c Mice Infected with Inhalational Burkholderia pseudomallei.
Antibiotics (Basel)
; 11(10)2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36290100
12.
Finafloxacin, a Novel Fluoroquinolone, Reduces the Clinical Signs of Infection and Pathology in a Mouse Model of Q Fever.
Front Microbiol
; 12: 760698, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34917048
13.
The Fluoroquinolone Finafloxacin Protects BALB/c Mice Against an Intranasal Infection With Francisella tularensis Strain SchuS4.
Front Microbiol
; 10: 904, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118924
14.
The lytic transglycosylase, LtgG, controls cell morphology and virulence in Burkholderia pseudomallei.
Sci Rep
; 9(1): 11060, 2019 07 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-31363151
15.
Disulfiram, an alcohol dependence therapy, can inhibit the in vitro growth of Francisella tularensis.
Int J Antimicrob Agents
; 54(1): 85-88, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029736
16.
Inhaled Liposomal Ciprofloxacin Protects against a Lethal Infection in a Murine Model of Pneumonic Plague.
Front Microbiol
; 8: 91, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28220110
17.
Trimethoprim/sulfamethoxazole (co-trimoxazole) prophylaxis is effective against acute murine inhalational melioidosis and glanders.
Int J Antimicrob Agents
; 41(6): 552-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23517714